These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8590992)

  • 1. Reduction by beta-adrenoceptor blockade of hypoxia-induced right heart hypertrophy in the rat.
    Ostman-Smith I
    Br J Pharmacol; 1995 Nov; 116(6):2698-702. PubMed ID: 8590992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat.
    Ostman-Smith I
    Br J Pharmacol; 1995 Nov; 116(6):2703-9. PubMed ID: 8590993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
    Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of aortic banding-induced cardiac hypertrophy by propranolol is independent of beta-adrenoceptor blockade.
    Marano G; Palazzesi S; Fadda A; Vergari A; Ferrari AU
    J Hypertens; 2002 Apr; 20(4):763-9. PubMed ID: 11910314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
    Kaumann AJ; Molenaar P
    Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia.
    Tual L; Morel OE; Favret F; Fouillit M; Guernier C; Buvry A; Germain L; Dhonneur G; Bernaudin JF; Richalet JP
    Pflugers Arch; 2006 Jul; 452(4):371-9. PubMed ID: 16639551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intermittent hypoxia on cardiovascular function, adrenoceptors and muscarinic receptors in Wistar rats.
    Germack R; Leon-Velarde F; Valdes De La Barra R; Farias J; Soto G; Richalet JP
    Exp Physiol; 2002 Jul; 87(4):453-60. PubMed ID: 12392109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic cardiac hypertrophy is not inhibited by cardioselective or non-selective beta-adrenoceptor antagonists.
    Dennis P; Vaughan Williams EM
    J Physiol; 1982 Mar; 324():365-74. PubMed ID: 6212672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.
    Hyltander A; Daneryd P; Sandström R; Körner U; Lundholm K
    Eur J Cancer; 2000 Feb; 36(3):330-4. PubMed ID: 10708933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade.
    Steinkraus V; Nose M; Scholz H; Thormählen K
    Br J Pharmacol; 1989 Feb; 96(2):441-9. PubMed ID: 2564293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists.
    Speiser Z; Gordon I; Rehavi M; Gitter S
    Eur J Pharmacol; 1991 Mar; 195(1):75-83. PubMed ID: 1676680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenoceptor antagonism and the hyperthyroid rat heart.
    Amos G; Kerr D; Sernia C; Brown L
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):336-43. PubMed ID: 7526070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-1 and beta-2, but not alpha-1 and alpha-2, adrenoceptor blockade delays rat cutaneous wound healing.
    Romana-Souza B; Santos JS; Monte-Alto-Costa A
    Wound Repair Regen; 2009; 17(2):230-9. PubMed ID: 19320892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
    John GW; Doxey JC; Walter DS; Reid JL
    Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of beta adrenoceptor blockade with atenolol on myocardial cellular and subcellular hypertrophy in spontaneously hypertensive rats.
    Lauva IK; Tomanek RJ
    Anat Rec; 1983 Dec; 207(4):615-22. PubMed ID: 6142665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
    Ellison KE; Gandhi G
    Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of beta1-3-adrenoceptors in blood pressure control at rest and during tyramine-induced norepinephrine release in spontaneously hypertensive rats.
    Berg T; Piercey BW; Jensen J
    Hypertension; 2010 May; 55(5):1224-30. PubMed ID: 20231523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of β-adrenoceptor activation on haemodynamics during hypoxic stress in rats.
    Ji Q; Zhang Y; Zhang H; Liu J; Cao C; Yuan Z; Ma Q; Zhang W
    Exp Physiol; 2020 Sep; 105(9):1660-1668. PubMed ID: 32706493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
    Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I
    Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.